XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities:    
Loss for the period $ (2,530,325) $ (1,226,764)
Adjustments to reconcile loss for the period to net cash used in operating activities:    
Depreciation 16,380 11,704
Stock-based compensation 374,180 950
Change in the fair value of Warrants with down-round protection (84,099) (43,510)
Linkage difference on principal of loans from stockholders (1,367) (1,464)
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable 2,255 (17,294)
Decrease in inventory 78,416 44,101
Decrease in other current assets 190,590 152,969
(Decrease) increase in accounts payable (129,419) 269,474
Increase in other current liabilities 937,276 323,453
Net cash used in operating activities (1,146,113) (486,381)
Cash flows from investing activities:    
Purchase of property and equipment (1,477) (23,955)
Net cash used in investing activities (1,477) (23,955)
Cash flows from financing activities    
Credit from banking institutes 27,388
Proceeds allocated to Series C Preferred Stock, net of cash issuance expenses 1,738,259
Proceeds allocated to Series C Warrants, net of cash issuance expenses 860,812
Net cash provided by financing activities 2,599,071 27,388
Effect of exchange rate changes on cash and cash equivalents 38,686 5,648
Increase (decrease) in cash and cash equivalents 1,490,167 (477,300)
Cash and cash equivalents at beginning of the period 148,836 608,701
Cash and cash equivalents at end of the period $ 1,639,003 $ 131,401